Education
About Us
Working with TipRanks
Follow Us
Catalyst Pharmaceutical Partners (CPRX)
NASDAQ:CPRX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 588.99M | $ 491.73M | $ 398.20M | $ 214.20M | $ 140.83M |
| Gross Profit | $ 501.74M | $ 422.89M | $ 346.24M | $ 179.81M | $ 118.95M |
| Operating Income | $ 257.78M | $ 195.12M | $ 86.81M | $ 101.84M | $ 52.38M |
| EBITDA | $ 295.28M | $ 232.90M | $ 119.69M | $ 103.08M | $ 52.58M |
| Net Income | $ 214.33M | $ 163.89M | $ 71.41M | $ 83.08M | $ 39.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 709.17M | $ 517.55M | $ 137.64M | $ 298.39M | $ 191.27M |
| Total Assets | $ 1.10B | $ 851.41M | $ 470.11M | $ 375.63M | $ 237.79M |
| Total Debt | $ 2.35M | $ 3.19M | $ 3.56M | $ 3.89M | $ 4.20M |
| Net Debt | $ -706.82M | $ -514.37M | $ -134.08M | $ -294.50M | $ -167.24M |
| Total Liabilities | $ 149.71M | $ 123.78M | $ 82.23M | $ 75.21M | $ 30.96M |
| Stockholders' Equity | $ 954.27M | $ 727.63M | $ 387.88M | $ 300.42M | $ 206.83M |
| Cash Flow | |||||
| Free Cash Flow | $ 208.61M | $ 239.25M | $ 61.86M | $ 116.02M | $ 59.35M |
| Operating Cash Flow | $ 208.67M | $ 239.81M | $ 143.60M | $ 116.05M | $ 60.37M |
| Investing Cash Flow | $ -58.00K | $ -556.00K | $ -293.50M | $ 9.21M | $ -11.02M |
| Financing Cash Flow | $ -16.99M | $ 140.66M | $ -10.86M | $ 1.69M | $ -8.14M |